Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
Xeris Biopharma Holdings
XERS
$1.57B
| $131K | ﹤0.01% |
55,304
+32,507
| +143% | +$60K |
|
5352
CF Bankshares
CFBK
$234M
| $130K | ﹤0.01% |
6,629
+77
| +1% | +$1.26K |
|
5353
Fidelity Limited Term Bond ETF
FLTB
$436M
| $130K | ﹤0.01% |
2,648
+27
| +1% | +$1.3K |
|
|
HITI
5354
High Tide
HITI
$206M
| $130K | ﹤0.01% |
79,560
-10,026
| -11% | -$15.1K |
|
|
JPUS
5355
JPMorgan Diversified Return US Equity ETF
JPUS
$469M
| $130K | ﹤0.01% |
1,268
-3,324
| -72% | -$320K |
|
|
MTLS
5356
Materialise
MTLS
$400M
| $130K | ﹤0.01% |
19,770
-1,500
| -7% | -$8.86K |
|
|
TRTX
5357
TPG RE Finance Trust
TRTX
$609M
| $130K | ﹤0.01% |
19,902
+8,298
| +72% | +$50.1K |
|
5358
World Acceptance Corp
WRLD
$908M
| $130K | ﹤0.01% |
998
+173
| +21% | +$20.3K |
|
5359
Anterix
ATEX
$1.79B
| $129K | ﹤0.01% |
3,880
+2,034
| +110% | +$65.6K |
|
5360
Greif Class B
GEF.B
$4.2B
| $129K | ﹤0.01% |
1,950
+581
| +42% | +$38.4K |
|
5361
PetMed Express
PETS
$39.6M
| $129K | ﹤0.01% |
17,029
+3,229
| +23% | +$26.5K |
|
5362
Innovator US Equity Power Buffer ETF February
PFEB
$926M
| $129K | ﹤0.01% |
+3,957
| New | +$124K |
|
5363
Rimini Street
RMNI
$466M
| $129K | ﹤0.01% |
39,871
+33,281
| +505% | +$91.5K |
|
5364
Riverview Bancorp
RVSB
$106M
| $129K | ﹤0.01% |
20,240
+342
| +2% | +$2.01K |
|
5365
Sana Biotechnology
SANA
$1.06B
| $129K | ﹤0.01% |
31,488
+15,522
| +97% | +$57.2K |
|
|
TEI
5366
Templeton Emerging Markets Income Fund
TEI
$320M
| $129K | ﹤0.01% |
25,208
-2,822
| -10% | -$13.5K |
|
5367
Target Hospitality
TH
$1.74B
| $129K | ﹤0.01% |
13,259
+845
| +7% | +$10.5K |
|
5368
Waldencast
WALD
$173M
| $129K | ﹤0.01% |
11,778
+5,273
| +81% | +$49.9K |
|
|
FSP
5369
Franklin Street Properties
FSP
$50.8M
| $128K | ﹤0.01% |
50,000
-16,500
| -25% | -$35.6K |
|
|
SHYF
5370
DELISTED
The Shyft Group
SHYF
| $128K | ﹤0.01% |
10,464
+5,310
| +103% | +$64.9K |
|
5371
Xtrackers S&P 500 Growth ESG ETF
SNPG
$14.6M
| $128K | ﹤0.01% |
3,747
-301
| -7% | -$9.77K |
|
5372
Tilly's
TLYS
$122M
| $128K | ﹤0.01% |
16,969
+973
| +6% | +$7.83K |
|
5373
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.81B
| $128K | ﹤0.01% |
1,745
-3,316
| -66% | -$220K |
|
|
VTYX
5374
DELISTED
Ventyx Biosciences
VTYX
| $128K | ﹤0.01% |
51,772
+45,913
| +784% | +$436K |
|
|
ATYR
5375
aTyr Pharma
ATYR
$54.8M
| $128K | ﹤0.01% |
91,291
+10,318
| +13% | +$13.2K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.